COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2512: Articles 25111-25120  | Next

Bivalent binding of a fully human IgG to the SARS-CoV-2 spike proteins reveals mechanisms of potent neutralization
Wang, B., Asarnow, D., Lee, W.-H., Huang, C.-W., Faust, B., Ng, P. M. L., Ngoh, E. Z. X., Bohn, M., Bulkley, D., Pizzorno, A., Tan, H. C., Lee, C. Y., Minhat, R. A., Terrier, O., Soh, M. K., Teo, F. J., Yeap, Y. Y. C., Hu, Y., Seah, S. G. K., Maurer-Stroh, S., Renia, L., Hanson, B. J., Rosa-Calatrava, M., Manglik, A., Cheng, Y., Craik, C. S., Wang, C.-I.
10.1101/2020.07.14.203414 — Posted: 2020-07-15
Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: An endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations
Sarkar, R., Mitra, S., Chandra, P., Saha, P., Banerjee, A., Dutta, S., Chawla-Sarkar, M.
10.1101/2020.07.14.203463 — Posted: 2020-07-15
Alignment-free machine learning approaches for the lethality prediction of potential novel human-adapted coronavirus using genomic nucleotide
YIN, R., Luo, Z., Kwoh, C. K.
10.1101/2020.07.15.176933 — Posted: 2020-07-15
Bioinformatic analysis of shared B and T cell epitopes amongst relevant coronaviruses to human health: Is there cross-protection?
Pacheco-Olvera, D. L., Saint Remy-Hernandez, S., Acevedo-Ochoa, E., Arriaga-Pizano, L., Cerbulo-Vazquez, A., Ferat-Osorio, E., Rivera-Hernandez, T., Lopez-Macias, C.
10.1101/2020.07.14.202887 — Posted: 2020-07-15
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial.
Horby, P., Mafham, M., Linsell, L., Bell, J. L., Staplin, N., Emberson, J. R., Wiselka, M., Ustianowski, A., Elmahi, E., Prudon, B., Whitehouse, A., Felton, T., Williams, J., Faccenda, J., Underwood, J., Baillie, J. K., Chappell, L., Faust, S. N., Jaki, T., Jeffery, K., Lim, W. S., Montgomery, A., Rowan, K., Tarning, J., Watson, J. A., White, N. J., Juszczak, E., Haynes, R., Landray, M. J.
10.1101/2020.07.15.20151852 — Posted: 2020-07-15 Discussion: Onsite
Endocrine disrupting chemicals and COVID-19 relationships: a computational systems biology approach
Wu, Q., Coumoul, X., Grandjean, P., Barouki, R., Audouze, K.
10.1101/2020.07.10.20150714 — Posted: 2020-07-15
CHEST DRAIN AEROSOL GENERATION IN COVID-19 AND EMISSION REDUCTION USING A SIMPLE ANTI-VIRAL FILTER
DUFFY, C., KIDD, A., FRANCIS, S., TSIM, S., MCNAUGHTON, L., FERGUSON, K., FERGUSON, J., RODGERS, G., McGROARTY, C., SAYER, R., BLYTH, K. G.
10.1101/2020.07.13.20152264 — Posted: 2020-07-15
Association between epidemic dynamics of Covid-19 infection and ABO blood group types
Liu, Y., Steinacker, J. M., Haeussinger, L., Dinse-Lambracht, A.
10.1101/2020.07.12.20152074 — Posted: 2020-07-15
Climate & BCG: Effects on COVID-19 DeathGrowth Rates
Finlay, C., Bassett, B. A.
10.1101/2020.07.13.20152991 — Posted: 2020-07-15
Dissemination and co-circulation of SARS-CoV2 subclades exhibiting enhanced transmission associated with increased mortality in Western Europe and the United States
Hu, Y., Riley, L. W.
10.1101/2020.07.13.20152959 — Posted: 2020-07-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).